Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

Detalles Bibliográficos
Autores principales: Chen, Minting, Zhong, Keying, Tan, Jincheng, Meng, Mingjing, Liu, Chok Mei, Chen, Baisen, Huang, Chunhua, Wong, Hoi Leong Xavier, Bian, Zhaoxiang, Su, Tao, Kwan, Hiu Yee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567042/
https://www.ncbi.nlm.nih.gov/pubmed/34841696
http://dx.doi.org/10.1002/ctm2.564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567042/
https://www.ncbi.nlm.nih.gov/pubmed/34841696
http://dx.doi.org/10.1002/ctm2.564

Ejemplares similares